Shares of Natco Pharma surged nearly 9%, touching the 52-week high of Rs322.55, after company wins compulsary licence from Bayer
Natco will pay 6% royalty on sales to Bayer on Sorafenib.
....more info
Natco will pay 6% royalty on sales to Bayer on Sorafenib.
....more info